Mercedes acquires Turns Pharmaceuticals for $6.7 billion
Mercedes has announced its acquisition of Turns Pharmaceuticals for <strong>$6.7 billion</strong>, granting access to a promising treatment for <strong>blood cancer</strong>. This move comes as the company faces the expiration of a patent for one of its best-selling cancer drugs.